A Detailed Analysis of the Continuous Glucose Monitoring Systems Market Based on an Unprecedented Rate of Diabetes Prevalence Worldwide
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 217
Report ID: PMRREP33708
1. Executive Summary
1.1. Global Continuous Glucose Monitoring Systems Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Component Lifecycle Analysis
2.4. Continuous Glucose Monitoring Systems Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Vehicle Types
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Continuous Glucose Monitoring Systems Market Outlook: Component
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Component, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
3.3.3.1. Transmitters and Monitors
3.3.3.2. Sensors
3.3.3.3. Insulin Pump
3.4. Market Attractiveness Analysis: Component
3.5. Global Continuous Glucose Monitoring Systems Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Home Care Diagnostics
3.5.3.2. Hospitals
3.5.3.3. ICU/Critical Care
3.6. Market Attractiveness Analysis: End User
4. Global Continuous Glucose Monitoring Systems Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Component
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
5.5.1. Transmitters and Monitors
5.5.2. Sensors
5.5.3. Insulin Pump
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Home Care Diagnostics
5.6.2. Hospitals
5.6.3. ICU/Critical Care
5.7. Market Attractiveness Analysis
6. Europe Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Component
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
6.5.1. Transmitters and Monitors
6.5.2. Sensors
6.5.3. Insulin Pump
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Home Care Diagnostics
6.6.2. Hospitals
6.6.3. ICU/Critical Care
6.7. Market Attractiveness Analysis
7. East Asia Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Component
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
7.5.1. Transmitters and Monitors
7.5.2. Sensors
7.5.3. Insulin Pump
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Home Care Diagnostics
7.6.2. Hospitals
7.6.3. ICU/Critical Care
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Component
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
8.5.1. Transmitters and Monitors
8.5.2. Sensors
8.5.3. Insulin Pump
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Home Care Diagnostics
8.6.2. Hospitals
8.6.3. ICU/Critical Care
8.7. Market Attractiveness Analysis
9. Latin America Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Component
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
9.5.1. Transmitters and Monitors
9.5.2. Sensors
9.5.3. Insulin Pump
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Home Care Diagnostics
9.6.2. Hospitals
9.6.3. ICU/Critical Care
9.7. Market Attractiveness Analysis
10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Component
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2023 - 2030
10.5.1. Transmitters and Monitors
10.5.2. Sensors
10.5.3. Insulin Pump
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Home Care Diagnostics
10.6.2. Hospitals
10.6.3. ICU/Critical Care
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Herbalife Nutrition
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. GNC Holdings
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. NOW Health
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Nutramax Laboratories
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Nature's Bounty
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Banyan Botanicals
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Source Naturals
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Nutramarks Inc
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nature's Way Products
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Abbott
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Natural Immunogenics
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations